BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 26965464)

  • 1. Quantitative Susceptibility Mapping in Cerebral Cavernous Malformations: Clinical Correlations.
    Tan H; Zhang L; Mikati AG; Girard R; Khanna O; Fam MD; Liu T; Wang Y; Edelman RR; Christoforidis G; Awad IA
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1209-15. PubMed ID: 26965464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations.
    Girard R; Fam MD; Zeineddine HA; Tan H; Mikati AG; Shi C; Jesselson M; Shenkar R; Wu M; Cao Y; Hobson N; Larsson HBW; Christoforidis GA; Awad IA
    J Neurosurg; 2017 Jul; 127(1):102-110. PubMed ID: 27494817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of brainstem cavernous malformations: prospective hemorrhage rate and adverse factors in a consecutive prospective cohort.
    Li D; Wu ZY; Liu PP; Ma JP; Huo XL; Wang L; Zhang LW; Wu Z; Zhang JT
    J Neurosurg; 2020 Mar; 134(3):917-928. PubMed ID: 32168479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage.
    Zeineddine HA; Girard R; Cao Y; Hobson N; Fam MD; Stadnik A; Tan H; Shen J; Chaudagar K; Shenkar R; Thompson RE; McBee N; Hanley D; Carroll T; Christoforidis GA; Awad IA
    J Magn Reson Imaging; 2018 Apr; 47(4):1133-1138. PubMed ID: 28791783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of SWI sequences compared to T2*-weighted gradient echo sequences in the detection of cerebral cavernous malformations in the familial form.
    Sparacia G; Speciale C; Banco A; Bencivinni F; Midiri M
    Neuroradiol J; 2016 Oct; 29(5):326-35. PubMed ID: 27549150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations.
    Mikati AG; Tan H; Shenkar R; Li L; Zhang L; Guo X; Larsson HB; Shi C; Liu T; Wang Y; Shah A; Edelman RR; Christoforidis G; Awad I
    Stroke; 2014 Feb; 45(2):598-601. PubMed ID: 24302484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance.
    Carrión-Penagos J; Zeineddine HA; Polster SP; Girard R; Lyne SB; Koskimäki J; Romanos S; Srinath A; Zhang D; Cao Y; Stadnik A; Piedad K; Shenkar R; Awad IA
    J Neurosurg; 2020 Apr; 134(3):1147-1154. PubMed ID: 32244216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping.
    Tan H; Liu T; Wu Y; Thacker J; Shenkar R; Mikati AG; Shi C; Dykstra C; Wang Y; Prasad PV; Edelman RR; Awad IA
    Invest Radiol; 2014 Jul; 49(7):498-504. PubMed ID: 24619210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial.
    Lanfranconi S; Scola E; Bertani GA; Zarino B; Pallini R; d'Alessandris G; Mazzon E; Marino S; Carriero MR; Scelzo E; Faragò G; Castori M; Fusco C; Petracca A; d'Agruma L; Tassi L; d'Orio P; Lampugnani MG; Nicolis EB; Vasamì A; Novelli D; Torri V; Meessen JMTA; Al-Shahi Salman R; Dejana E; Latini R;
    Trials; 2020 May; 21(1):401. PubMed ID: 32398113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rupture risk analysis of cerebral cavernous malformation associated with developmental venous anomaly using susceptibility-weighted imaging.
    Zhang S; Ma L; Wu C; Wu J; Cao Y; Wang S; Zhao J
    Neuroradiology; 2020 Jan; 62(1):39-47. PubMed ID: 31482190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history and imaging prevalence of cavernous malformations in children and young adults.
    Al-Holou WN; O'Lynnger TM; Pandey AS; Gemmete JJ; Thompson BG; Muraszko KM; Garton HJ; Maher CO
    J Neurosurg Pediatr; 2012 Feb; 9(2):198-205. PubMed ID: 22295927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiosurgery for symptomatic solitary cerebral cavernous malformations considered high risk for resection.
    Lunsford LD; Khan AA; Niranjan A; Kano H; Flickinger JC; Kondziolka D
    J Neurosurg; 2010 Jul; 113(1):23-9. PubMed ID: 20170299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of preoperative diffusion tensor imaging in the surgical management of brainstem cavernous malformations.
    Flores BC; Whittemore AR; Samson DS; Barnett SL
    J Neurosurg; 2015 Mar; 122(3):653-62. PubMed ID: 25574568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral Venous Malformations in a Chinese Population: Clinical Manifestations, Radiological Characteristics, and Long-Term Prognosis.
    Kang K; Ju Y; Wang D; Li H; Sun L; Ma K; Zhao X; Lu J
    World Neurosurg; 2018 Dec; 120():e472-e479. PubMed ID: 30149153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliable? The Value of Early Postoperative Magnetic Resonance Imaging after Cerebral Cavernous Malformation Surgery.
    Chen B; Göricke S; Wrede K; Jabbarli R; Wälchli T; Jägersberg M; Sure U; Dammann P
    World Neurosurg; 2017 Jul; 103():138-144. PubMed ID: 28391022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma knife radiosurgery for symptomatic brainstem intra-axial cavernous malformations.
    Park SH; Hwang SK
    World Neurosurg; 2013 Dec; 80(6):e261-6. PubMed ID: 23010066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertebral Intraosseous Vascular Malformations in a Familial Cerebral Cavernous Malformation Population: Prevalence, Histologic Features, and Associations With CNS Disease.
    Tandberg SR; Bocklage T; Bartlett MR; Morrison LA; Nelson J; Hart BL
    AJR Am J Roentgenol; 2020 Feb; 214(2):428-436. PubMed ID: 31825263
    [No Abstract]   [Full Text] [Related]  

  • 18. Surgical outcomes and natural history of intramedullary spinal cord cavernous malformations: a single-center series and meta-analysis of individual patient data: Clinic article.
    Badhiwala JH; Farrokhyar F; Alhazzani W; Yarascavitch B; Aref M; Algird A; Murty N; Kachur E; Cenic A; Reddy K; Almenawer SA
    J Neurosurg Spine; 2014 Oct; 21(4):662-76. PubMed ID: 25062285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical course of untreated thalamic cavernous malformations: hemorrhage risk and neurological outcomes.
    Tian KB; Zheng JJ; Ma JP; Hao SY; Wang L; Zhang LW; Wu Z; Zhang JT; Li D
    J Neurosurg; 2017 Sep; 127(3):480-491. PubMed ID: 27834594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cavernous malformations.
    Smith ER; Scott RM
    Neurosurg Clin N Am; 2010 Jul; 21(3):483-90. PubMed ID: 20561497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.